PURPOSE Providing a geriatric assessment (GA) summary with management
recommendations to oncologists reduces clinician-rated toxicity in older patients with …

Abstract The Danish Prostate Cancer Group is launching the randomized trial, PROstate
PROTON Trial 1 (NCT05350475), that compares photons and protons to the prostate and …

Background Patients with high‐risk prostate cancer (HRPC) have multiple accepted
treatment options. Because there is no overall survival benefit of one option over another …

Background PROs assessments arguably provide the most accurate description of the
patient experience, as they provide a direct quote from the patient without the filter of a …

Purpose Implications of radiation dose exposure to the urethra on urinary morbidity after
prostate radiotherapy are poorly understood, especially by long-term patient-reported …

Purpose To report clinical and dosimetric characteristics of 5-fraction stereotactic ablative
radiotherapy (SABR) using intensity modulated proton therapy (IMPT) for localized prostate …

People living with cancer have a profound need to understand any potential negative
impacts of treatment on their everyday lives and whether the treatment itself could cause …

Purpose The feasibility of simulation-free radiation therapy (SFRT) has been demonstrated
but information regarding its routine care impact and scalability is lacking. Methods and …

Background Accurate self-reported symptomatic toxicity documentation via the Patient-
Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO …

Objective The aim of this work was to evaluate the acute toxicity and quality-of-life (QOL)
impact of ultrahypofractionated whole pelvis radiation therapy (WPRT) compared with …